Literature DB >> 35939623

Approaches to discern if microbiome associations reflect causation in metabolic and immune disorders.

Marijana Basic1, Dominique Dardevet2, Peter Michael Abuja3, Silvia Bolsega1, Stéphanie Bornes4, Robert Caesar5, Francesco Maria Calabrese6, Massimo Collino7, Maria De Angelis6, Philippe Gérard8, Miguel Gueimonde9, François Leulier10, Eva Untersmayr11, Evelien Van Rymenant12, Paul De Vos13, Isabelle Savary-Auzeloux2.   

Abstract

Our understanding of microorganisms residing within our gut and their roles in the host metabolism and immunity advanced greatly over the past 20 years. Currently, microbiome studies are shifting from association and correlation studies to studies demonstrating causality of identified microbiome signatures and identification of molecular mechanisms underlying these interactions. This transformation is crucial for the efficient translation into clinical application and development of targeted strategies to beneficially modulate the intestinal microbiota. As mechanistic studies are still quite challenging to perform in humans, the causal role of microbiota is frequently evaluated in animal models that need to be appropriately selected. Here, we provide a comprehensive overview on approaches that can be applied in addressing causality of host-microbe interactions in five major animal model organisms (Caenorhabditis elegans, Drosophila melanogaster, zebrafish, rodents, and pigs). We particularly focused on discussing methods available for studying the causality ranging from the usage of gut microbiota transfer, diverse models of metabolic and immune perturbations involving nutritional and chemical factors, gene modifications and surgically induced models, metabolite profiling up to culture-based approached. Furthermore, we addressed the impact of the gut morphology, physiology as well as diet on the microbiota composition in various models and resulting species specificities. Finally, we conclude this review with the discussion on models that can be applied to study the causal role of the gut microbiota in the context of metabolic syndrome and host immunity. We hope this review will facilitate important considerations for appropriate animal model selection.

Entities:  

Keywords:  Gut microbiota; caenorhabditis elegans; causality; drosophila melanogaster; human; immunity; metabolism; pig; rodent; zebrafish

Mesh:

Year:  2022        PMID: 35939623      PMCID: PMC9361767          DOI: 10.1080/19490976.2022.2107386

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  139 in total

Review 1.  A Comprehensive Understanding of Dietary Effects on C. elegans Physiology.

Authors:  Jie-Jun Zhou; Lei Chun; Jian-Feng Liu
Journal:  Curr Med Sci       Date:  2019-10-14

2.  Probabilistic Invasion Underlies Natural Gut Microbiome Stability.

Authors:  Benjamin Obadia; Z T Güvener; Vivian Zhang; Javier A Ceja-Navarro; Eoin L Brodie; William W Ja; William B Ludington
Journal:  Curr Biol       Date:  2017-06-15       Impact factor: 10.834

3.  Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz
Journal:  Science       Date:  2010-03-04       Impact factor: 47.728

4.  Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans.

Authors:  Brian D Muegge; Justin Kuczynski; Dan Knights; Jose C Clemente; Antonio González; Luigi Fontana; Bernard Henrissat; Rob Knight; Jeffrey I Gordon
Journal:  Science       Date:  2011-05-20       Impact factor: 47.728

Review 5.  The mouse gut microbiome revisited: From complex diversity to model ecosystems.

Authors:  Thomas Clavel; Ilias Lagkouvardos; Michael Blaut; Bärbel Stecher
Journal:  Int J Med Microbiol       Date:  2016-03-05       Impact factor: 3.473

6.  Gut microbiota from twins discordant for obesity modulate metabolism in mice.

Authors:  Vanessa K Ridaura; Jeremiah J Faith; Federico E Rey; Jiye Cheng; Alexis E Duncan; Andrew L Kau; Nicholas W Griffin; Vincent Lombard; Bernard Henrissat; James R Bain; Michael J Muehlbauer; Olga Ilkayeva; Clay F Semenkovich; Katsuhiko Funai; David K Hayashi; Barbara J Lyle; Margaret C Martini; Luke K Ursell; Jose C Clemente; William Van Treuren; William A Walters; Rob Knight; Christopher B Newgard; Andrew C Heath; Jeffrey I Gordon
Journal:  Science       Date:  2013-09-06       Impact factor: 47.728

7.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

8.  Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus.

Authors:  Deepshika Ramanan; Mei San Tang; Rowann Bowcutt; P'ng Loke; Ken Cadwell
Journal:  Immunity       Date:  2014-07-31       Impact factor: 31.745

9.  Murine Genetic Background Overcomes Gut Microbiota Changes to Explain Metabolic Response to High-Fat Diet.

Authors:  Zahra Safari; Aurélia Bruneau; Magali Monnoye; Mahendra Mariadassou; Catherine Philippe; Kurt Zatloukal; Philippe Gérard
Journal:  Nutrients       Date:  2020-01-21       Impact factor: 6.706

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.